R. G. Fassett

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

Richard A. Brigandi, Brendan M. Johnson, Coreen Oei et al. · American Journal of Kidney Diseases · 2016 · 159 citations · Full text

Medicine, Hematology, Pharmacology +17

DETECTION OF GLOMERULAR BLEEDING BY PHASE-CONTRAST MICROSCOPY

R. G. Fassett, BernadetteA. Horgan, Thomas Mathew · The Lancet · 1982 · 158 citations

Medicine, Nephrology, Pathology +10

Retinal Basement Membrane Abnormalities and the Retinopathy of Alport Syndrome

Judy Savige, John Liu, Delia Cabrera DeBuc et al. · Investigative Ophthalmology & Visual Science · 2010 · 100 citations

Medicine, Ophthalmology, Pathology +17

Central blood pressure measurement may improve risk stratification

James E. Sharman, Michael Stowasser, R. G. Fassett et al. · Journal of Human Hypertension · 2008 · 87 citations · Full text

Medicine, Cardiology, Risk Assessment +10

A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome

Hayat Dagher, Mark Buzza, Deb Colville et al. · American Journal of Kidney Diseases · 2001 · 69 citations

Life Sciences, Genetics, Pathology +11